Printer Friendly

F.D.A. review of Crown Laboratories Inc. continues.

LAS VEGAS--(BUSINESS WIRE)--June 7, 1996--Crown Laboratories Inc. (AMEX EC: CLL) reported that its final F.D.A. review process is proceeding according to standard F.D.A. review procedures.

As anticipated, Crown's manufacturing personnel recently met with the F.D.A. to discuss the company's pending submission. There were requests for some information for clarification purposes.

Crown and the National Food Laboratory collaborated on its request and fulfilled the follow-up submission on June 5. At this time, Crown is not aware of any outstanding issues and is awaiting the F.D.A.'s response.

Matters discussed in this news release contain forward-looking statements that involve risks and uncertainties including the time needed to complete any additional information on test results required by the F.D.A. No assurance can be given as to the time ultimately taken by the F.D.A. to complete their review.

These and other risks are detailed from time to time in the company's S.E.C. Reports, including Form 10-QSB for the quarter ended March 31, 1996, and Form 10-KSB for the year ended Dec. 31, 1996.

CONTACT: Crown Laboratories

Lawrence Rosenthal, 610/667-4448
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 7, 1996
Words:192
Previous Article:CLI Obtains $15 Million Credit Facility with Subsidiary of Nations Bank, Greyrock Business Credit.
Next Article:SEACOR Holdings Inc. announces definitive agreement with CNN for the acquisition of six vessels and files registration statement for underwritten...


Related Articles
High-tech tooth repair: incisive software may allow dentists to stop worrying about making a good impression.
Study details misconduct in drug research.
A look at the FDA from the MS point of view.
Betaseron bulletin.
Testing Yourself for HIV-1, the Virus that Causes AIDS.
AVAILABILITY OF IMPLANTS.
An overview of the drug approval process. (FDA Overview).
Never mind the science.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters